These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 2682692

  • 1. Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition. Results of a placebo-controlled double-blind study.
    Schöpf J, Baumann P, Lemarchand T, Rey M.
    Pharmacopsychiatry; 1989 Sep; 22(5):183-7. PubMed ID: 2682692
    [Abstract] [Full Text] [Related]

  • 2. Lithium addition in endogenous depressions resistant to tricyclic antidepressants or related drugs: relation to the status of the pituitary-thyroid axis.
    Schöpf J, Lemarchand T.
    Pharmacopsychiatry; 1994 Sep; 27(5):198-201. PubMed ID: 7838890
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of bupropion in tricyclic-resistant or intolerant patients.
    Stern WC, Harto-Truax N, Bauer N.
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):148-52. PubMed ID: 6406447
    [Abstract] [Full Text] [Related]

  • 4. Treatment of depressions resistant to tricyclic antidepressants, related drugs or MAO-inhibitors by lithium addition: review of the literature.
    Schöpf J.
    Pharmacopsychiatry; 1989 Sep; 22(5):174-82. PubMed ID: 2682691
    [Abstract] [Full Text] [Related]

  • 5. On the problems of switching from intravenous to oral administration in drug treatment of endogenous depression--a placebo-controlled double-blind trial with doxepin.
    Adler L, Hajak G, Lehmann K, Kunert HJ, Hoffmann G, Issinger J, Böke J, Huether G, Rüther E.
    Pharmacopsychiatry; 1997 Mar; 30(2):62-9. PubMed ID: 9131726
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of the effectiveness of two treatment strategies in inpatients with a depressive disorder. A double-blind study of imipramine followed by lithium addition versus fluvoxamine followed by lithium addition].
    Birkenhäger TK, van den Broek WW, Mulder PG, Bruijn JA, Moleman P.
    Tijdschr Psychiatr; 2006 Mar; 48(4):271-81. PubMed ID: 16955991
    [Abstract] [Full Text] [Related]

  • 7. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J, Barkin RL.
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 9. Lack of advantage for imipramine combined with lithium versus imipramine alone in the treatment of major depression--a double-blind controlled study.
    Shahal B, Piel E, Mecz L, Kremer I, Klein E.
    Biol Psychiatry; 1996 Dec 01; 40(11):1181-3. PubMed ID: 8931923
    [No Abstract] [Full Text] [Related]

  • 10. Delayed onset of action of antidepressant drugs? Survey of results of Zurich meta-analyses.
    Stassen HH, Angst J, Delini-Stula A.
    Pharmacopsychiatry; 1996 May 01; 29(3):87-96. PubMed ID: 8738312
    [Abstract] [Full Text] [Related]

  • 11. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD, Holman SL, Sayler ME, Potvin JH.
    J Clin Psychiatry; 1994 Feb 01; 55(2):50-9. PubMed ID: 8077155
    [Abstract] [Full Text] [Related]

  • 12. Treatment of depression in bipolar disorder: new directions for research.
    Zornberg GL, Pope HG.
    J Clin Psychopharmacol; 1993 Dec 01; 13(6):397-408. PubMed ID: 8120153
    [Abstract] [Full Text] [Related]

  • 13. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
    Bremner JD.
    J Clin Psychiatry; 1995 Nov 01; 56(11):519-25. PubMed ID: 7592505
    [Abstract] [Full Text] [Related]

  • 14. A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy.
    McDougle CJ, Price LH, Goodman WK, Charney DS, Heninger GR.
    J Clin Psychopharmacol; 1991 Jun 01; 11(3):175-84. PubMed ID: 1820757
    [Abstract] [Full Text] [Related]

  • 15. Treatment of refractory depression with combination reserpine and tricyclic antidepressant therapy.
    Amsterdam JD, Berwish N.
    J Clin Psychopharmacol; 1987 Aug 01; 7(4):238-42. PubMed ID: 3305592
    [Abstract] [Full Text] [Related]

  • 16. Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.
    van Moffaert M, de Wilde J, Vereecken A, Dierick M, Evrard JL, Wilmotte J, Mendlewicz J.
    Int Clin Psychopharmacol; 1995 Mar 01; 10(1):3-9. PubMed ID: 7622801
    [Abstract] [Full Text] [Related]

  • 17. Lithium augmentation therapy in refractory depression-update 2002.
    Bauer M, Forsthoff A, Baethge C, Adli M, Berghöfer A, Döpfmer S, Bschor T.
    Eur Arch Psychiatry Clin Neurosci; 2003 Jun 01; 253(3):132-9. PubMed ID: 12904977
    [Abstract] [Full Text] [Related]

  • 18. Lithium potentiation of tricyclic antidepressants following lack of T3 potentiation.
    Garbutt JC, Mayo JP, Gillette GM, Little KY, Mason GA.
    Am J Psychiatry; 1986 Aug 01; 143(8):1038-9. PubMed ID: 3089033
    [Abstract] [Full Text] [Related]

  • 19. An open study of triiodothyronine augmentation of tricyclic antidepressants in inpatients with refractory depression.
    Birkenhäger TK, Vegt M, Nolen WA.
    Pharmacopsychiatry; 1997 Jan 01; 30(1):23-6. PubMed ID: 9065966
    [Abstract] [Full Text] [Related]

  • 20. Lithium and desipramine versus desipramine alone in the treatment of severe major depression: a preliminary study.
    Cappiello A, McDougle CJ, Delgado PL, Malison RT, Jatlow P, Charney DS, Heninger GR, Price LH.
    Int Clin Psychopharmacol; 1998 Sep 01; 13(5):191-8. PubMed ID: 9817623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.